Related Experiment Video
Updated: Jun 20, 2026
Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain
Marco Sifringer1, Daniela Brait, Ulrike Weichelt
1Department of Neonatology, Charité-Universitätsmedizin Berlin, Berlin, Germany. marco.sifringer@charite.de
Insights
Recombinant erythropoietin (rEpo) protects developing rat brains from oxygen toxicity by reducing oxidative stress and inflammatory markers. This treatment helps mitigate hyperoxia-induced neurological damage in immature brains.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Oxygen toxicity is a significant factor in neurological damage in preterm infants.
- Hyperoxia in infant rodent brains causes neurodegeneration, inflammation, and impaired growth signaling.
Purpose of the Study:
- To investigate the protective effects of recombinant erythropoietin (rEpo) against hyperoxia-induced oxidative stress in the developing rat brain.
- To assess the impact of rEpo on glutathione levels, lipid peroxidation, heme oxygenase-1 (HO-1), and acetylcholinesterase (AChE) expression.
Main Methods:
- Developing Wistar rats (6 days old) were exposed to 80% oxygen for 2-48 hours.
- Rats received intraperitoneal injections of rEpo (20,000 IU/kg) or saline.
- Control groups were maintained under room air.
Main Results:
- rEpo treatment significantly reduced oxidized glutathione (GSSG) and malondialdehyde levels.
- rEpo upregulated reduced glutathione (GSH) and induced heme oxygenase-1 (HO-1) expression.
- rEpo suppressed hyperoxia-induced upregulation of acetylcholinesterase variants (AChE-S and AChE-R), indicating protection of cholinergic signaling.
Conclusions:
- rEpo mitigates oxygen toxicity in the developing brain by reducing oxidative stress markers.
- rEpo limits hyperoxia-induced changes in HO-1 and cholinergic functions, suggesting a neuroprotective mechanism.
Abstract:
Oxygen toxicity contributes to the pathogenesis of adverse neurological outcome in survivors of preterm birth in clinical studies. In infant rodent brains, hyperoxia triggers widespread apoptotic neurodegeneration, induces pro-inflammatory cytokines and inhibits growth factor signaling cascades. Since a tissue-protective effect has been observed for recombinant erythropoietin (rEpo), we hypothesized that rEpo would influence hyperoxia-induced oxidative stress in the developing rat brain. The aim of this study was to investigate the level of glutathione (reduced and oxidized), lipid peroxidation and the expression of heme oxygenase-1 (HO-1) and acetylcholinesterase (AChE) after hyperoxia and rEpo treatment. Six-day-old Wistar rats were exposed to 80% oxygen for 2-48 h and received 20,000 IU/kg rEpo intraperitoneally (i.p.). Sex-matched littermates kept under room air and injected with normal saline or rEpo served as controls. Treatment with rEpo significantly reduced hyperoxia-induced upregulation of oxidized glutathione (GSSG) and malondialdehyde, a product of lipid breakdown, whereas reduced glutathione (GSH) was upregulated by rEpo. In parallel, hyperoxia-treated immature rat brains revealed rEpo-suppressible upregulation of synaptic AChE-S as well as of the stress-inducible AChE-R variant, together predicting rEpo-protected cholinergic signaling and restrained inflammatory reactions. Furthermore, treatment with rEpo induced upregulation of HO-1 on mRNA, protein and activity level in the developing rat brain. Our results suggest that rEpo generates its protective effect against oxygen toxicity by a reduction of diverse oxidative stress parameters and by limiting the stressor-inducible changes in both HO-1 and cholinergic functions.
